Healthcare -
Biotechnology - NASDAQ - US
$ 1.95
0 %
$ 409 M
Market Cap
-1.26
P/E
ALLO - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative ALLO - Allogene Therapeutics, Inc.
71.7 M
LAST VALUE
-1.65%
2 YEAR CAGR
11.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR